image
Healthcare - Biotechnology - NASDAQ - US
$ 0.5683
9.2 %
$ 23.2 M
Market Cap
-0.16
P/E
BALANCE SHEET
73.7 M ASSETS
-64.20%
130 M LIABILITIES
0.88%
-56.5 M EQUITY
-73.60%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition BioXcel Therapeutics, Inc.
image
Current Assets 72.1 M
Cash & Short-Term Investments 65.2 M
Receivables 71 K
Other Current Assets 6.85 M
Non-Current Assets 1.56 M
Long-Term Investments 0
PP&E 1.47 M
Other Non-Current Assets 87 K
Current Liabilities 27.3 M
Accounts Payable 13.7 M
Short-Term Debt 346 K
Other Current Liabilities 13.3 M
Non-Current Liabilities 103 M
Long-Term Debt 101 M
Other Non-Current Liabilities 1.9 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
ASSETS
Cash & Cash Equivalents 65.2 193.7 233.0 213.1 32.4 42.6 0.9 0
Short Term Investments 0 0 0 0 0 0 0 0
Receivables 71 K 0.2 0 0 0 0.1 0 0
Inventory 2.0 2.0 0 0 0 0 0 0
Other Current Assets 4.9 6.9 3.8 6.9 1.7 0.5 3 K 2 K
Total Current Assets 72.1 202.9 233.0 217.1 34.1 43.2 0.9 2 K
PP&E 1.5 2.1 2.5 2.8 2.2 0.3 4 K 5 K
Intangible Assets 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0
Other Long Term Assets 87 K 0.9 3.9 87 K 51 K 51 K 0.5 0
Other Assets 0 0 0 0 0 0 0 0
Total Assets 73.7 205.9 239.4 219.9 36.4 43.5 1.4 7 K
LIABILITIES
Accounts Payable 13.7 10.2 4.7 4.0 5.0 1.6 0.4 0.3
Short Term Debt 0.3 0.3 0.3 0.2 0 0 0.4 0
Other Current Liabilities 13.2 22.3 11.4 6.9 3.5 3.1 1.5 52 K
Total Current Liabilities 27.3 32.9 16.7 11.8 8.5 4.7 2.3 0.3
Long Term Debt 101.0 94.6 2.2 2.8 1.0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0
Other Liabilities 1.9 1.6 (1.1) (1.4) 0 0 0 0
Total Liabilities 130.2 129.1 17.8 13.2 9.5 4.7 2.3 0.3
EQUITY
Common Stock 30 K 28 K 28 K 24 K 18 K 16 K 10 K 0
Retained Earnings (590.6) (411.5) (245.8) (138.9) (56.7) (23.7) (4.5) 0
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 18 K 1 K 0
Total Equity (56.5) 76.8 221.7 206.7 26.9 38.9 (1.0) (0.3)
Total Liabilities and Equity 73.7 205.9 239.4 219.9 36.4 43.5 1.4 7 K
SHARES OUTSTANDING
Common Shares Outstanding 29.1 28.0 26.4 21.7 16.3 14.6 15.2 15.6 15.9